Open-Label Study of H5 Vaccine in Participants of Protocol 04-077

NCT00402649 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

35

Enrollment

NIH

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)